The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Tovey Christopher J. since 2019.
This trader's CIK number is 1754163.
At the time of last reporting, Tovey Christopher J. was the EVP, COO & Managing Director E of Jazz Pharmaceuticals Plc. (stock ticker symbol JAZZ).
Also see all insider trading activities at Jazz Pharmaceuticals Plc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2020 | GWPH | 0 | $0 | 122,028 | $1,426,779 | 122,028 | $121 |
| 2019 | GWPH | 0 | $0 | 266,736 | $4,204,619 | 266,736 | $214,100 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2022 | JAZZ | 0 | $0 | 5,209 | $833,440 | 4,032 | $80 |
1. Gw Pharmaceuticals Plc (GWPH)
2. Jazz Pharmaceuticals Plc (JAZZ)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2020-12-01 | GWPH | Option Ex | 28,560 | .00 | 28 |
| 2020-11-30 | GWPH | Option Ex | 93,468 | .00 | 93 |
| 2020-12-01 | GWPH | Sale | 28,560 | 11.77 | 336,008 |
| 2020-11-30 | GWPH | Sale | 93,468 | 11.67 | 1,090,771 |
| 2019-06-03 | GWPH | Sale | 64,800 | 14.61 | 946,728 |
| 2019-06-03 | GWPH | Option Ex | 64,800 | 3.24 | 209,952 |
| 2019-05-15 | GWPH | Option Ex | 1,200 | 3.29 | 3,948 |
| 2019-05-15 | GWPH | Sale | 1,200 | 15.01 | 18,012 |
| 2019-05-07 | GWPH | Option Ex | 200,736 | .00 | 200 |
| 2019-05-07 | GWPH | Sale | 200,736 | 16.14 | 3,239,879 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2022-07-05 | JAZZ | Option Ex | 4,032 | .02 | 80 |
| 2022-07-05 | JAZZ | Sale | 5,209 | 160.00 | 833,440 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Tovey Christopher J. (EVP, COO & Managing Director E of Jazz Pharmaceuticals Plc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.